HAL vs STOK · P/E 9.3, $19.05B cap vs rev $36.6M
Halliburton Company (HAL) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. STOK currently screens at market cap $1.88B.
Not investment advice. Open the HAL and STOK stock pages for the full models.
Not investment advice.